LeserbriefKommentar
Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?
Heart and Vessels · 19.08.2026
DOI: 10.1007/s00380-026-02743-7 ↗Kurz gefasst
Leserbrief in der Zeitschrift Heart and Vessels, online erschienen am 19.08.2026. Verfasst von Xiaoxia Xiao. Beteiligte Einrichtung: Department of Cardiology, The Third Hospital of Changsha, Changsha, 410001, China. csxiaoxiaoxia@163.com. Die Arbeit nennt 3 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiology, The Third Hospital of Changsha, Changsha, 410001, China. csxiaoxiaoxia@163.com.
Zitieren
APA
Xiao, X. (2026). Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?. Heart and Vessels. https://doi.org/10.1007/s00380-026-02743-7
Vancouver
Xiao X. Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?. Heart and Vessels. 2026. doi:10.1007/s00380-026-02743-7
BibTeX
@article{Xiao2026,
author = {Xiao, Xiaoxia},
title = {Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?},
journal = {Heart and Vessels},
year = {2026},
doi = {10.1007/s00380-026-02743-7}
}
EUVIMED